MORGAN HALL: Open Payments
NPI 1912742693 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 1 | $135 |
| PFIZER INC. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Indigo System, LEQVIO, VELSIPITY, ELIQUIS, Assure WCD, FARXIGA, CAPVAXIVE, SHINGRIX.
Industry payments across LA — which companies pay providers there.
